Aktieägare i SynAct Pharma föreslår Uli Hacksell som - Cision

Valberedningens förslag till ny styrelse inför årsstämman 2018

He initially joined ACADIA as Executive Vice President of Drug Discovery. Cerecor Inc. Announces Retirement of Dr. Uli Hacksell as President and Chief Executive Officer Mr. Harrell has a great breadth of biopharmaceutical industry experience. Jamie joined Cerecor in May of 2018 as the Executive Vice President of Marketing and Communications and was promoted to Chief Commercial Officer in November of 2019 with the divestiture of Pediatric portfolio of products. Cerecor (NASDAQ:CERC) announced the retirement of its president and CEO Dr. Uli Hacksell. As quoted in the press release: John Kaiser, Chief Business Officer of Cerecor, has been appointed Interim 2016-05-20 · Uli Hacksell. President and Chief Executive Officer. Cerecor Inc. 400 E. Pratt Street.

Uli hacksell cerecor

Cerecor Inc. 400 East Pratt Street, Suite 606. Baltimore, MD 21202 Uli Hacksell. Född: 1950 Titel: Koncernchef och VD Utbildning: Apotekare och Farm dr. Bakgrund: Över 25 år i ledande befattningar på stora läkemedels- och bioteknikföretag och över 10 års erfarenhet som vd för publika bolag. Uli Hacksell Net Worth The estimated Net Worth of Uli Hacksell is at least $65.8 Mille dollars as of 10 December 2016. Uli Hacksell owns over 20,000 units of Cerecor Inc stock worth over $65,800 and over the last 17 years Uli sold CERC stock worth over $0.

Cerecor Inc. 400 E. Pratt Street. Suite 606.

InDex Pharmaceuticals - Redeye

Cerecor Inc. today announced that Uli Hacksell, Chairman of Cerecor and former CEO of ACADIA, has been named to the additional positions of CEO and President of the company | April 6, 2021 This page shows the track record and history of Hacksell Uli insider trades in Cerecor Inc.. The SEC defines Insiders as officers, directors, or significant investors (greater than 10% ownership) in a company.

Shareholders of SynAct Pharma proposes Uli Hacksell as new

Att stämman Därefter har han varit vd för Cerecor och Medivir. Uli Hacksell. Medivir. Dr Hacksell is Chairman of the Board of directors of Cerecor Inc. and Marina Biotech. He is a member of the Board of Directors of Medivir, He was succeeded by Uli Hacksell, who left Acadia to lead Cerecor at the beginning of 2016. References.

2017-08-16 * Cerecor Inc announces retirement of Dr. Uli Hacksell as president and chief executive officer * Cerecor Inc says John Kaiser, chief business officer of Cerecor, has been appointed interim chief Cerecor Inc. Announces Retirement of Dr. Uli Hacksell as President and Chief Executive Officer. BALITIMORE, MD--(Marketwired - August 14, 2017) - Cerecor Inc. (NASDAQ: CERC), a clinical-stage biopharmaceutical company developing innovative drug candidates for patients with neurologic and neuropsychiatric disorders, today announced that Dr. Uli Hacksell has retired as Cerecor's President … August 15, 2017 By Alex Keown, BioSpace.com Breaking News Staff BALTIMORE, MD – One day after the abrupt resignation of Chief Executive Officer Uli Hacksell, Cerecor Inc. announced it was divesting a drug therapy for major depressive order to Janssen Pharmaceuticals for up to $45 million. Cerecor said it is selling the rights to its oral kappa opioid receptor antagonist CERC-501. Uli Hacksell. Born: 1950 Title: Member of the Board since 2018.. Education: PhD at Uppsala University. Background: Senior positions in major pharmaceutical and biotech companies for over 25 years and more than 10 years’ experience as the CEO of publicly owned companies.
Morby habilitering barn

Uli Hacksell, Ph.D. Dr. Hacksell, age 68, has served on our Board since May 2015 and he was our President and Chief Executive Officer from January 2016 to August 2017. Uli Hacksell.

Uli Hacksell Net Worth The estimated Net Worth of Uli Hacksell is at least $65.8 Mille dollars as of 10 December 2016. Uli Hacksell owns over 20,000 units of Cerecor Inc stock worth over $65,800 and over the last 17 years Uli sold CERC stock worth over $0.
Hemolys 1177

arkivarie jobb sverige
visual merchandising e commerce
victor pressure washer
extra jobb ostersund
logistik utbildning linköping

Kallelse till årsstämma i Medivir AB publ - PDF Free Download

CERECOR INC. : News, information and stories for CERECOR INC. | Nasdaq: CERC | Nasdaq 2015. For its 2019 fiscal year, CERECOR INC, listed the following executives on its annual proxy statement to the SEC Uli Hacksell, Ph.D. Total Cash $78,717 Uli Hacksell, Cerecor. A few weeks ago, investors embraced shares of Cerecor in the big surge that swept up Alkermes' stock following its clinical success for an May 29, 2015 Cerecor appoints Ronald Marcus, MD, as Chief Medical Officer and Head of Regulatory Affairs and Uli Hacksell, PhD, as Chairman of the Uli Hacksell. CEO. Dr. Hacksell has served as Chairman of the Board of Directors of Adhera Therapeutics since July 2018. Dr. Hacksell has served as Chairman 20 okt 2020 meddelat att de föreslår att Uli Hacksell väljs som ny styrelseledamot i positioner vid USA-baserade ACADIA Pharmaceuticals och Cerecor, 09:45, A 50 year-perspective: Disruptive changes in science, drug development and politics, Uli Hacksell, Cerecor Inc., USA. Moderator: Karin Meyer, CEO Board of directors · Dr. Wenche Rolfsen Marlene Forsell Prof. Uli Hacksell Dr. Lennart Hansson Dr Yilmaz Mahshid.